<SEC-DOCUMENT>0000899243-23-010438.txt : 20230404
<SEC-HEADER>0000899243-23-010438.hdr.sgml : 20230404
<ACCEPTANCE-DATETIME>20230404170359
ACCESSION NUMBER:		0000899243-23-010438
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230403
FILED AS OF DATE:		20230404
DATE AS OF CHANGE:		20230404

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			HUFF CURTIS W
		CENTRAL INDEX KEY:			0001250127

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		23799089

	MAIL ADDRESS:	
		STREET 1:		4510 LAMESA HWY
		CITY:			SNYDER
		STATE:			TX
		ZIP:			79549

	FORMER NAME:	
		FORMER CONFORMED NAME:	HUFT CURTIS W
		DATE OF NAME CHANGE:	20030628

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Freebird Investments LLC
		CENTRAL INDEX KEY:			0001971406
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		23799090

	BUSINESS ADDRESS:	
		STREET 1:		2800 POST OAK BLVD., SUITE 2000
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
		BUSINESS PHONE:		713-961-0118

	MAIL ADDRESS:	
		STREET 1:		2800 POST OAK BLVD., SUITE 2000
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Freebird Partners LP
		CENTRAL INDEX KEY:			0001955231
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		23799091

	BUSINESS ADDRESS:	
		STREET 1:		2800 POST OAK BLVD.
		STREET 2:		SUITE 2000
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
		BUSINESS PHONE:		713-961-0118

	MAIL ADDRESS:	
		STREET 1:		2800 POST OAK BLVD.
		STREET 2:		SUITE 2000
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eterna Therapeutics Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1035 CAMBRIDGE STREET
		STREET 2:		SUITE 18A
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		10531 4S COMMONS DRIVE
		STREET 2:		SUITE 166-550
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Brooklyn ImmunoTherapeutics, Inc.
		DATE OF NAME CHANGE:	20210325

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2023-04-03</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000748592</issuerCik>
        <issuerName>Eterna Therapeutics Inc.</issuerName>
        <issuerTradingSymbol>ERNA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001955231</rptOwnerCik>
            <rptOwnerName>Freebird Partners LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>2800 POST OAK BLVD, SUITE 2000</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>HOUSTON</rptOwnerCity>
            <rptOwnerState>TX</rptOwnerState>
            <rptOwnerZipCode>77056</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001971406</rptOwnerCik>
            <rptOwnerName>Freebird Investments LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>2800 POST OAK BLVD, SUITE 2000</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>HOUSTON</rptOwnerCity>
            <rptOwnerState>TX</rptOwnerState>
            <rptOwnerZipCode>77056</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001250127</rptOwnerCik>
            <rptOwnerName>HUFF CURTIS W</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>2800 POST OAK BLVD, SUITE 2000</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>HOUSTON</rptOwnerCity>
            <rptOwnerState>TX</rptOwnerState>
            <rptOwnerZipCode>77056</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.005 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>272582</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F1"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Common Stock Purchase Warrant</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.28</value>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2023-06-02</value>
            </exerciseDate>
            <expirationDate>
                <value>2028-06-02</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, par value $0.005 per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>424928</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">This report is filed jointly by Freebird Partners LP, a Texas limited partnership (&quot;Freebird Partners&quot;), Freebird Investments LLC, a Texas limited liability company (&quot;Freebird Investments&quot;), and Curtis W. Huff (each a &quot;Reporting Person&quot; and collectively, the &quot;Reporting Persons&quot;) in connection with their respective direct and indirect ownership of common stock, par value $0.0005 of Eterna Therapeutics Inc. (the &quot;Company&quot;). These securities of the Company are held of record by Freebird Partners. Freebird Investments serves as the general partner of Freebird Partners. Curtis W. Huff is the sole member of Freebird Investments. By virtue of these relationships, each of Freebird Investments and Mr. Huff may be deemed to share beneficial ownership of the securities held of record by Freebird Partners.</footnote>
        <footnote id="F2">Pursuant to that certain Securities Purchase Agreement, as announced in the Issuer's Current Report on Form 8-K filed with the SEC on November 25, 2022, the Company issued that certain Common Stock Purchase Warrant (&quot;Warrant&quot;) to Freebird Partners LP on December 2, 2022, in substantially the form as the form of warrant filed as Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission (the &quot;SEC&quot;) on December 2, 2022. The Warrant becomes exercisable on June 2, 2023, and may be exercised through June 2, 2028, at an exercise price of $3.28 per share of Common Stock.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>Freebird Partners LP, By: Freebird Investments LLC, its general partner, By: /s/ Curtis W. Huff, Chairman and President</signatureName>
        <signatureDate>2023-04-04</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Freebird Investments LLC, By: /s/ Curtis W. Huff, Chairman and President</signatureName>
        <signatureDate>2023-04-04</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Curtis W. Huff</signatureName>
        <signatureDate>2023-04-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
